Ocugen(OCGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCGN Ocugen

盘前交易 11-18 05:10:42 EST

0.9386

-0.0614

-6.14%

最高1.02	最低0.9380	成交量519.54万
今开1.02	昨收1.00	日振幅8.20%
总市值2.73亿	流通市值2.70亿	总股本2.91亿
成交额496.94万	换手率1.81%	流通股本2.87亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCGN","market":"US","secType":"STK","nameCN":"Ocugen","latestPrice":0.9386,"timestamp":1731704400000,"preClose":1,"halted":0,"volume":5195376,"delay":0,"floatShares":287320773,"shares":291320280,"eps":-0.196621,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0614,"latestTime":"11-18 05:10:42 EST","open":1.02,"high":1.02,"low":0.938,"amount":4969442.6057376005,"amplitude":0.082,"askPrice":1.08,"askSize":100,"bidPrice":0.94,"bidSize":4100,"shortable":3,"etf":0,"ttmEps":-0.196621,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731940200000},"adr":0,"listingDate":1417582800000,"adjPreClose":0.9386,"postHourTrading":{"tag":"盘后","latestPrice":0.95,"preClose":0.9386,"latestTime":"19:59 EST","volume":81084,"amount":76470.0533,"timestamp":1731718767654},"volumeRatio":0.9982182085514973,"impliedVol":1.6312,"impliedVolPercentile":0.52},"requestUrl":"/m/hq/s/OCGN","defaultTab":"news","newsList":[{"id":"2483309449","title":"Ocugen, Inc.盘中异动 早盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483309449?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:01","pubTimestamp":1731686463,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时01分，Ocugen, Inc.股票出现波动，股价急速下跌5.00%。截至发稿，该股报0.950美元/股，成交量130.157万股，换手率0.45%，振幅7.00%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为3.47%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111600010398e42ff1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111600010398e42ff1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","OCGN","BK4568"],"gpt_icon":0},{"id":"2483942854","title":"Ocugen, Inc.盘中异动 下午盘快速跳水5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483942854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483942854?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:07","pubTimestamp":1731528433,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时07分，Ocugen, Inc.股票出现异动，股价大幅跳水5.38%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为680.52%、561.42%、168.94%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为140.00%、86.83%、73.71%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114040713a234f61e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114040713a234f61e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","BK4568","OCGN"],"gpt_icon":0},{"id":"2482738332","title":"Ocugen, Inc.盘中异动 早盘大幅上涨5.96%报1.045美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738332?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:32","pubTimestamp":1731335522,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时32分，Ocugen, Inc.股票出现异动，股价大幅拉升5.96%。截至发稿，该股报1.045美元/股，成交量21.1986万股，换手率0.07%，振幅2.03%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122320398e41c4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122320398e41c4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4563","OCGN"],"gpt_icon":0},{"id":"2481101969","title":"Ocugen, Inc.盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101969?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076276,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分，Ocugen, Inc.股票出现波动，股价急速下跌5.56%。截至发稿，该股报1.02美元/股，成交量102.73万股，换手率0.36%，振幅0.93%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223116971a55b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223116971a55b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","OCGN","BK4139","BK4568"],"gpt_icon":0},{"id":"2481074536","title":"Ocugen Inc  预计每股亏损 5 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481074536","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481074536?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:15","pubTimestamp":1730902540,"startTime":"0","endTime":"0","summary":"Ocugen Inc  预计每股亏损 5 美分 - 财报前瞻Ocugen公司OCGN.OQ OCGN.O将于11月8日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。LSEG分析师对Ocugen公司的平均预期是每股亏损5美分。华尔街对 Ocugen Inc 的 12 个月目标价中位数为 6.50 美元，高于其最新收盘价 0.95 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD2FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCGN"],"gpt_icon":0},{"id":"2480054554","title":"Ocugen, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480054554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480054554?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:46","pubTimestamp":1730396809,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日01时46分，Ocugen, Inc.股票出现波动，股价快速下挫5.26%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为3.63%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Quince Therapeutics, Inc.、Mimedx Group, Inc涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为269.02%、240.93%、194.39%，振幅较大的相关个股有Vaccinex, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Gri Bio, Inc.，振幅分别为47.15%、46.15%、45.95%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101014649a2033dcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101014649a2033dcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","BK4568","OCGN"],"gpt_icon":0},{"id":"2479398702","title":"Ocugen, Inc.盘中异动 急速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479398702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479398702?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:46","pubTimestamp":1730220364,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时46分，Ocugen, Inc.股票出现波动，股价大幅跳水5.12%。截至发稿，该股报0.958美元/股，成交量237.241万股，换手率0.82%，振幅8.09%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000460498e3f281&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000460498e3f281&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN","BK4568","BK4563","BK4139"],"gpt_icon":0},{"id":"2478489821","title":"Ocugen, Inc.盘中异动 股价大涨5.97%报0.980美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478489821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478489821?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:36","pubTimestamp":1730122583,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时36分，Ocugen, Inc.股票出现异动，股价快速上涨5.97%。截至发稿，该股报0.980美元/股，成交量26.0587万股，换手率0.09%，振幅5.28%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213624ab7bc687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213624ab7bc687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4568","OCGN"],"gpt_icon":0},{"id":"2478894939","title":"Ocugen, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478894939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478894939?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:07","pubTimestamp":1729865229,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时07分，Ocugen, Inc.股票出现异动，股价急速上涨5.01%。截至发稿，该股报0.938美元/股，成交量36.1603万股，换手率0.13%，振幅3.88%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220709ab740cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025220709ab740cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","OCGN","BK4139","BK4563"],"gpt_icon":0},{"id":"2474727387","title":"BUZZ-Ocugen 在美国食品药品管理局解除糖尿病眼损伤疗法的临床搁置后上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2474727387","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474727387?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:58","pubTimestamp":1728489522,"startTime":"0","endTime":"0","summary":"    10月9日 - ** 抗糖尿病药物生产商Ocugen  股价上涨1.75%，报0.98美元** 在美国食品和药物管理局解除临床搁置后，该公司的糖尿病黄斑水肿治疗药物, OCU200 现在可以开始第一阶段临床试验了  ** 糖尿病黄斑水肿是一种由于视网膜血管异常增生而导致糖尿病患者眼睛受损的疾病。** 美国 FDA 于 2023 年 4 月要求公司在开始试验前提供有关生产实践和产品规格的更多信息 ** 公司打算为该药物寻求更多适应症，以治疗糖尿病视网膜病变和湿性老年性黄斑变性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4139","BK4568","OCGN"],"gpt_icon":0},{"id":"2472573339","title":"Ocugen, Inc.盘中异动 急速上涨5.54%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472573339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472573339?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:36","pubTimestamp":1728048985,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时36分，Ocugen, Inc.股票出现波动，股价急速上涨5.54%。截至发稿，该股报1.000美元/股，成交量6.3955万股，换手率0.02%，振幅3.58%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042136269719e600&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042136269719e600&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","OCGN","BK4139","BK4568"],"gpt_icon":0},{"id":"2471472380","title":"Ocugen, Inc.盘中异动 股价大跌5.05%报0.969美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471472380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471472380?lang=zh_cn&edition=full","pubTime":"2024-09-30 23:35","pubTimestamp":1727710514,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日23时35分，Ocugen, Inc.股票出现波动，股价大幅跳水5.05%。截至发稿，该股报0.969美元/股，成交量141.09万股，换手率0.49%，振幅5.88%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093023351498e39e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093023351498e39e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","OCGN","BK4139","BK4563"],"gpt_icon":0},{"id":"2470938081","title":"Ocugen, Inc.盘中异动 早盘股价大涨5.03%报1.035美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470938081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470938081?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:48","pubTimestamp":1727444894,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时48分，Ocugen, Inc.股票出现异动，股价大幅上涨5.03%。截至发稿，该股报1.035美元/股，成交量22.1706万股，换手率0.08%，振幅3.04%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092721481598e39678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092721481598e39678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4563","OCGN","BK4139"],"gpt_icon":0},{"id":"2470261268","title":"Ocugen, Inc.盘中异动 早盘股价大涨5.00%报1.025美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470261268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470261268?lang=zh_cn&edition=full","pubTime":"2024-09-25 21:48","pubTimestamp":1727272134,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日21时48分，Ocugen, Inc.股票出现异动，股价急速上涨5.00%。截至发稿，该股报1.025美元/股，成交量34.1118万股，换手率0.12%，振幅3.07%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925214854a1dc79ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925214854a1dc79ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","OCGN","BK4568"],"gpt_icon":0},{"id":"2462571324","title":"BUZZ-Ocugen 因完成早期基因治疗试验的患者用药量而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2462571324","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462571324?lang=zh_cn&edition=full","pubTime":"2024-08-28 20:43","pubTimestamp":1724848991,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月28日 - ** 药物开发商Ocugen公司  股价盘前上涨1.5%至1.35美元 ** 该公司表示，其早期试验的第三批病人已经完成了用药，该试验测试的是一种改良基因疗法OCU410ST，用于治疗Stargardt病。** 斯塔加特病是一种遗传性眼病，会导致视网膜变性和视力丧失** 三名患者接受了试验中最高剂量--OCGN--的单次视网膜下注射。** OCU410ST有可能在手术室通过视网膜下注射进行一次性治疗--OCGN** 试验将评估OCU410ST的安全性和有效性，分两个阶段进行** 截至上次收盘，该公司股价在今年翻了一番多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","OCGN","BUZZ","BK4563"],"gpt_icon":0},{"id":"2460007328","title":"Ocugen, Inc.盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460007328","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460007328?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:55","pubTimestamp":1724162149,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时55分，Ocugen, Inc.股票出现异动，股价快速跳水5.43%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为2224.17%、692.04%、245.57%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、Biomotion Sciences C/Wts Exp 15/08/2029 、泰坦制药，振幅分别为155.95%、78.89%、57.57%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820215550ab5ea410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820215550ab5ea410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4563","OCGN","BK4139"],"gpt_icon":0},{"id":"2460809736","title":"Ocugen, Inc.2024财年第二财季实现净利润-15.28百万美元，同比增加33.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460809736","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460809736?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910650,"startTime":"0","endTime":"0","summary":"8月18日，Ocugen, Inc.公布财报，公告显示公司2024财年第二财季净利润为-15.28百万美元，同比增加33.36%；其中营业收入为1.14百万美元，每股基本收益为-0.04美元。从资产负债表来看，Ocugen, Inc.总负债23.62百万美元，其中短期债务1.77百万美元，资产负债比为1.72，流动比率为1.04。机构评级：截至2024年8月18日，当前有3家机构对Ocugen, Inc.目标价做出预测，其中目标均价为7.00美元，其中最低目标价为6.00美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006319f340765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006319f340765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCGN"],"gpt_icon":0},{"id":"2458838987","title":"Ocugen, Inc.盘中异动 股价大涨5.20%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458838987","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458838987?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:41","pubTimestamp":1723473694,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时41分，Ocugen, Inc.股票出现波动，股价大幅拉升5.20%。截至发稿，该股报1.32美元/股，成交量118.906万股，换手率0.41%，振幅4.80%。Ocugen, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812224134af9717b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812224134af9717b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCGN","BK4563","BK4568"],"gpt_icon":0},{"id":"2458599653","title":"Ocugen, Inc.盘中异动 早盘大幅跳水5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458599653","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458599653?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:48","pubTimestamp":1723211282,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时48分，Ocugen, Inc.股票出现异动，股价急速下跌5.47%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Adma Biologics Inc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为41.51%、33.28%、11.05%，振幅较大的相关个股有An2 Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.、Cingulate Inc.，振幅分别为22.48%、20.58%、18.72%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809214802af96d3a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809214802af96d3a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCGN","BK4563","BK4568"],"gpt_icon":0},{"id":"2457023516","title":"Ocugen, Inc.盘中异动 股价大涨11.52%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457023516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457023516?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951116,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时31分，Ocugen, Inc.股票出现波动，股价急速上涨11.52%。截至发稿，该股报1.36美元/股，成交量60.6712万股，换手率0.21%，振幅4.11%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062131569f1435d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062131569f1435d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","OCGN","BK4139","BK4563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocugen.com","stockEarnings":[{"period":"1week","weight":-0.0483},{"period":"1month","weight":-0.0005},{"period":"3month","weight":-0.2431},{"period":"6month","weight":-0.5086},{"period":"1year","weight":1.5943},{"period":"ytd","weight":0.6323}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocugen, Inc.是根据马萨诸塞州的联邦法律注册成立于2000年6月28日，并在马萨诸塞州沃尔瑟姆进行主要业务运营。他们是一家生物制药公司，专注于开发治疗失明疾病的基因疗法和开发疫苗以挽救 COVID-19的生命。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.096086},{"month":2,"riseRate":0.4,"avgChangeRate":0.526041},{"month":3,"riseRate":0.3,"avgChangeRate":-0.035582},{"month":4,"riseRate":0.4,"avgChangeRate":0.069808},{"month":5,"riseRate":0.4,"avgChangeRate":-0.063081},{"month":6,"riseRate":0.3,"avgChangeRate":-0.045035},{"month":7,"riseRate":0.5,"avgChangeRate":0.131573},{"month":8,"riseRate":0.4,"avgChangeRate":0.067478},{"month":9,"riseRate":0.2,"avgChangeRate":-0.264629},{"month":10,"riseRate":0.4,"avgChangeRate":0.012908},{"month":11,"riseRate":0.3,"avgChangeRate":-0.202705},{"month":12,"riseRate":0.555556,"avgChangeRate":0.478442}],"exchange":"NASDAQ","name":"Ocugen","nameEN":"Ocugen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocugen(OCGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocugen(OCGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocugen,OCGN,Ocugen股票,Ocugen股票老虎,Ocugen股票老虎国际,Ocugen行情,Ocugen股票行情,Ocugen股价,Ocugen股市,Ocugen股票价格,Ocugen股票交易,Ocugen股票购买,Ocugen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocugen(OCGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocugen(OCGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}